In terms of diagnosis, immunohistochemical analysis of prostate cancer specimens with a range of Gleason scores revealed that STEAP1 could be a suitable candidate to distinguish patients with cancer from patients without tumor (15). This evidence concerns the gene STEAP1 and neoplasm.